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obstructive lung diseases (MOLDs), like cystic fibrosis and chronic
obstructive pulmonary disease, affect a spectrum of subjects globally.
In MOLDs, the airway mucus becomes hyperconcentrated, increasing
osmotic and viscoelastic moduli and impairing mucus clearance.
MOLD research requires relevant sources of healthy airway mucus for
experimental manipulation and analysis. Mucus collected from endo-
tracheal tubes (ETT) may represent such a source with benefits, e.g.,
in vivo production, over canonical sample types such as sputum or
human bronchial epithelial (HBE) mucus. Ionic and biochemical
compositions of ETT mucus from healthy human subjects were
characterized and a stock of pooled ETT samples generated. Pooled
ETT mucus exhibited concentration-dependent rheologic properties
that agreed across spatial scales with reported individual ETT samples
and HBE mucus. We suggest that the practical benefits compared with
other sample types make ETT mucus potentially useful for MOLD
research.
cystic fibrosis; muco-obstructive lung disease; mucus; mucus bio-
chemistry; mucus biophysics
INTRODUCTION
The airway surface liquid (ASL) is a protective bilayer
composed of the mucus layer and the periciliary layer (PCL)
(7). MUC5B and MUC5AC are the primary secreted mucins
in airway mucus and, with 1,000 other proteins, provide
the mucus layer with its characteristic viscoelastic proper-
ties (23, 45). The PCL consists of grafted (tethered) poly-
meric mucins and other glycoproteins that are bound to and
lubricate the cilia as they coordinately beat to propel the
mucus from the lung (7, 8).
In health, the mucus and periciliary layer are coordinately
hydrated to maintain efficient mucus clearance (7). Ciliary beat
in health in a well-hydrated PCL environment is unrestricted
by friction or negative osmotic interactions with the mucus
layer. However, in muco-obstructive lung diseases (MOLDs)
such as chronic obstructive pulmonary disease and cystic
fibrosis (CF), the mucus layer becomes hyperconcentrated (i.e.,
isotonically dehydrated) (16, 19, 22, 32). The hyperconcen-
trated mucus (i.e., 4% solids) has increased osmotic and
viscoelastic moduli that slow clearance and produce mucus
stasis (2, 6). Static mucus is proinflammatory and the site of
bacterial infection, which generates a positive-feedback mech-
anism that further increases mucus secretion/concentration in
the form of increased MUC5AC-to-MUC5B ratios (22) and
increased DNA content (10). Despite the need for physiolog-
ically relevant, healthy reference mucus, it is difficult to gen-
erate sufficient material (mucus) to study intact mucus or the
components of mucus function in health or dysfunction in
disease.
Currently, human airway mucus is sourced from induced
sputum (IS) in healthy subjects (2, 10, 21), spontaneous spu-
tum from subjects with disease, or from human bronchial
epithelial (HBE) cell culture surfaces (7, 19). Both “normal”
and disease-associated sputum have strengths and weaknesses
as sample types. Sputum induction in healthy subjects is
relatively low-risk and minimally invasive but has two limita-
tions. First, induction dilutes mucus and, since rheology is
highly dependent on concentration (19), may perturb measured
viscoelastic properties. Second, induction requires a trained
health care team to perform the procedure and prepare the
sample. In diseased patients, e.g., CF, sputum can be obtained
in large volumes (~5 mL) and often without induction (i.e.,
“spontaneously”) (1, 5, 13). In certain diseased samples, spu-
tum is subject to rapid proteolytic degradation of the mucin
polymer network and polymer-dependent mechanical proper-
ties (21). Infection and inflammation also increase DNA con-
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centrations in diseased sputum (10), which, by its stiff nature
(~10 times stiffer than mucins) (40, 42), may significantly alter
mucus rheological properties. CF sputum also has poor test-
retest reliability in rheological assessments (37).
HBE cell culture is an effective way to obtain sterile,
“healthy” airway mucus that is relatively free of proteolytic
activity, DNA, or other contamination. Furthermore, it is tun-
able to various concentrations, allowing for the study of con-
centration-dependent viscoelastic effects (19). However, HBE
mucus does not contain the vascular compartment contribu-
tions to mucus and is labor intensive to obtain, requiring the
care of a full-time laboratory technician to produce ~10 mL of
2% solids mucus from 120 cultures of 1 million cells per
month.
In this study we investigated whether mucus obtained from
the tips of endotracheal tubes (ETT) from normal subjects,
without a history of lung disease or smoking, undergoing
elective surgical procedures might be a practical source of
mucus for biophysical studies and biochemistry. ETT mucus
can be obtained in relatively large volumes (~0.6 mL per ET
tube) as a by-product of outpatient surgery and, consequently,
is readily available, and is not additionally invasive as a
collection technique. While reports have appeared on ETT
mucus (44), concerns about mucus dehydration due to evapo-
ration (hypertonic dehydration) during intubation and surgery
were not fully addressed. Herein, we describe the feasibility of
collecting native airway mucus from ETT and compare its
rheological and biochemical properties to those of HBE mucus,
induced healthy sputum, and spontaneous CF sputum.
METHODS
Endotracheal tube collection and mucus recovery. ETTs were
collected by members of the Department of Anesthesiology at the
University of North Carolina (UNC) Hospital in Chapel Hill as
approved by the UNC Institutional Review Board (protocol no.
11-0413). The tips (approximately the last 10 cm) of the ETTs were
removed upon completion of surgical procedures. The tips were
placed in a 50-mL conical tube, set on ice for transport to the UNC
Marsico Lung Institute, and centrifuged at 400 g upon delivery to
harvest the mucus. Each tip yielded ~600 L of mucus (see Table 1
and Supplemental Table S1; all Supplemental material is available at
https://doi.org/10.5281/zenodo.3351590). Samples were used imme-
diately or snap-frozen and stored at 80°C to reduce proteolysis.
Collection of HBE mucus, induced healthy sputum, and spontane-
ous CF sputum. HBE mucus was harvested from cell cultures and
pooled as previously described (17). Briefly, HBE cells were grown
on 1-cm2 Transwell inserts until confluent and mucus producing.
Mature cultures were washed with phosphate-buffered saline (PBS),
and washings were aspirated to remove surface debris and mucus.
Mucus was dialyzed to a high-concentration working stock and frozen
for later use. Healthy induced (38) and CF (18) sputum samples were
collected under the approval of the University of North Carolina
Institutional Review Board protocol no. 15-2431 and prepared for
characterization and analysis as outlined previously (18). Demo-
graphic information for each sample type is available in the respective
references above.
Measurement of mucus Na and K concentrations. Evaporative
water loss from ETT mucus can occur during intubation, even with
ventilation with nearly 100% humidified air, and during transport to
the laboratory. Because salt concentrations in normal mucus are
isotonic with plasma, salt concentration can be used as an index of
mucus evaporative water loss (25). Additionally, mucus in healthy
induced sputum (IS) samples can be relatively dilute compared with
the airways due to salivary contamination. Because saliva has a very
low salt content (9), measuring Na and K concentrations can be
used to estimate relative dilution of airway mucus during induction.
Accordingly, 50-L aliquots of each ETT and IS sample were used
for determination of Na and K concentrations. Mucus samples
were diluted into an equal volume of 6 N HCl-10% trichloroacetic
acid and maintained at 70°C for 24 h (Optima, Fisher, Pittsburgh, PA).
Following centrifugation, Na and K concentrations were measured
in the supernatant by inductive-coupled plasma optical emission
spectrometry (Optima 4300 DV, PerkinElmer, Norwalk, CT). Quality
assurance checks were obtained using a second multielement standard
(SPEX CertiPrep, Metuchen, NJ). A multielement standard (VHG
Laboratories, Manchester, NH) was used for the calibration curve.
Pooling and dilution of mucus for rheological characterization
across concentrations. A “stock” ETT mucus (Table 2) was generated
by pooling 150 L aliquots from the 15 isotonic ETT samples
described in Table 1. The 15 samples were thawed, combined (vol-
ume  2.25 mL), and mixed by trituration in the presence of protease
inhibitors (0.5 tablet; Roche Diagnostics, Mannheim, Germany) to
prevent sample degradation. The stock was then mixed overnight on
a rotator at 4°C. Aliquots of the pooled stock (4.6% solids) were
removed, diluted, and mixed overnight at 4°C in PBS to generate 2%,
3%, and 4% solids samples.
Table 1. Patient and sample characteristics for isotonic ETT mucus samples
Age, yr Sex Race Intubation Time, h Anesthesia Sample Volume, L % Solids Na, mM K, mM Na/K Ratio 2(NaK)
40 M Black 5.0 Isoflurane 700 4.84 121.08 30.98 3.91 304
35 F Indian 1.5 Sevoflurane 550 10.04 110.52 23.40 4.72 268
58 N Cauc 3.0 Isoflurane 550 3.45 123.39 47.19 2.61 341
72 M Cauc 1.0 Sevoflurane 600 3.36 84.39 37.11 2.27 243
58 F Cauc 2.0 Sevoflurane 600 3.39 117.67 29.37 4.01 294
70 F Cauc 3.0 Isoflurane 650 5.45 120.53 27.07 4.45 295
67 M Indian 6.0 Desflurane 450 9.03 143.53 21.09 6.81 329
84 M Cauc 1.5 Isoflurane 1,150 3.66 135.55 26.60 5.10 324
68 M Cauc 1.0 Sevoflurane 600 3.18 125.54 21.07 5.96 293
21 M Black 1.5 Sevoflurane 550 6.26 121.86 45.90 2.65 336
40 F Cauc 2.5 Sevoflurane 550 4.42 118.82 27.59 4.31 293
47 M Cauc 2.0 Isoflurane 600 3.00 124.50 30.10 4.14 309
37 F Cauc 2.0 Isoflurane 500 7.63 100.16 29.41 3.41 259
43 M Black 2.0 Sevoflurane 750 3.15 132.49 32.95 4.02 331
87 F Cauc 3.0 Sevoflurane 600 3.98 119.96 25.18 4.76 317
Mean 2.5 627 4.99 120.00 30.33 4.21 290
Cauc, Caucasian.
Determination of mucin concentrations in ETT and HBE mucus
and sputum. A portion of the stock was reserved for biochemical
characterization of mucus concentration (% solids), mucin and protein
concentrations, mucin molecular weight (MW), and mucin radius of
gyration (Rg) (16). In brief, ETT mucus samples were first solubilized
1:1 in 6 M guanidinium HCl (hereinafter GuHCl; Fisher Scientific,
Fairlawn, NJ) and, subsequently, diluted 1:200 in 200 mM sodium
chloride with 10 mM EDTA and 0.01% sodium azide (hereinafter
called light-scattering buffer, i.e., LSB) to suit instrument sensitivities.
The concentration and conformation of mucins, e.g., MW and Rg,
were determined by gel permeation chromatography in series with
multiangle laser light scattering (MALLS) and differential refractom-
etry. A 500 L sample was added to a Sepharose CL-2B column (GE
Health Care Life Sciences) and eluted with LSB at a flow rate of 0.5
mL/min. Effluents were passed through an in-line multiangle laser
photometer (DAWN Heleos, Wyatt Technology) coupled to a refrac-
tometer (Trex, Wyatt Technology) to measure light scattering and
sample concentration, respectively. The mass of mucins injected into
the system was determined by differential refractometry, while
mucin MW and Rg were determined by best fit of scattering data at
multiple angles to a second-order Berry model. Those values are
given in Table 2.
HBE cells were prepared and cultured at an air-liquid interface, as
previously described (26). The mucin and protein compositions of %
solids concentration-matched mucus harvested from HBE cultures
were also measured. In parallel, a second, concentration-matched ETT
pool was prepared from the same 15 ETT samples for comparison
with HBE by MALLS, as described above. Total protein concentra-
tions in ETT and HBE samples were determined by MALLS using a
desalting column (GE Healthcare Life Sciences) with otherwise iden-
tical methods, as described above (33).
Individual protein constituents of the ETT and HBE mucus were
determined by mass spectrometry as outlined in the Supplementary
Methods (available at https://doi.org/10.5281/zenodo.3351590). Briefly,
100 L of the pooled ETT sample were denatured in 6 M GuHCl and
digested for assessment by mass spectrometry in a Dionex ultimate
3000 RSLCnano system coupled to a hybrid quadrupole Orbitrap
mass spectrometer with a nanospray source (Q-Exactive, Thermo
Fisher, Bremen, Germany). Proteins were identified by searching
against the most current human database (Proteome Discover 1.4) and
quantified using Scaffold version 4 (Proteome Software) and the
normalized total precursor intensity.
Analysis of O-glycosylation of ETT mucin, sputum, and HBE cells.
At 43 days in culture, HBE cells were washed with isotonic medium
and harvested by scraping. After pelleting, the cells were stored frozen
at 80°C until analyzed. Frozen cell pellets were thawed, homoge-
nized in ice-cold water, and extracted with organic solvents to remove
lipids and generate a lipid-free protein preparation for subsequent
glycan analysis, as previously described (3, 4). Briefly, O-linked
glycans were released from glycoprotein preparations by reductive
-elimination, yielding intact, reduced structures. Following cleanup,
the released O-linked glycans were permethylated and analyzed by
nanospray ionization multidimensional mass spectrometry (NSI-MSn)
using instruments with linear and orbital ion trap capabilities (LTQ-
Orbi, Thermo Fisher). Three biological replicates of cells cultured
from the same donor were analyzed. Graphical representations of
monosaccharide residues are presented in accordance with the broadly
accepted Symbolic Nomenclature for Glycans, and O-linked glycan
analysis was performed in keeping with the MIRAGE guidelines for
glycomic studies (46, 49).
Rheology via cone-and-plate rheometer. Characterization of the
bulk viscoelasticity of ETT mucus at designated concentrations was
performed via cone (20 mm diameter, 1° deflection) and plate rhe-
ometry. Forty microliters of mucus was loaded onto the Peltier plate
of a DHR-3 rheometer (TA Instruments, New Castle, DE). Oscillatory
shear testing was performed over a range of small strain magnitudes
(0.02–10% strain) to determine the linear viscoelastic regimen (LVR)
for the elastic (G=) and viscous (G) moduli. In the LVR, G= and G
are independent of shear strain, allowing for the frequency depen-
dence of the viscoelastic moduli to be assessed across a range of
0.1–10 radians/s (18). This methodology was used for all mucus types
studied, with at least three technical replicates per sample type.
Particle-tracking microrheology. While bulk rheological measure-
ments of G= and G characterize the macroscopic properties of the
mucus gel, particle-tracking microrheology (PTMR) assesses the
mechanical properties of mucus at the length scale of its constituent
biopolymers (27, 44). In brief, the thermally driven motion of 1-m-
diameter carboxylated FluoSpheres (Thermo Fisher, Fremont, CA),
henceforth referred to as “beads,” was tracked to determine the
viscoelastic properties of the gel. Bead motion was recorded for 30 s
at a rate of 60 frames/s using a 	40 air objective on a Nikon Eclipse
TE2000U microscope. Individual bead trajectories were measured
automatically using a custom Python program that uses TrackPy
(https://doi.org/10.5281/zenodo.34028) for bead localization and track-
ing. Bead motion was converted to mean squared displacement (MSD)
and complex viscosity (
*) values in accordance with the mathemat-
ics described previously (19, 31).
Statistical methods. All statistical analyses were performed in
Matlab (2017, MathWorks, Natick, MA). Differences in measured
values or trends were deemed statistically significant where P 
  0.05. Differences between sample means were assessed by t-test
using the ttest2 function in Matlab, and differences in trends were
assessed by two-way ANOVA using the Matlab function anova2.
RESULTS
Selection and characterization of ETT samples for Na, K,
and solids concentrations. A total of 77 samples were pro-
cessed for % solids (see below), and dominant cation (Na 
K) concentration measurements were made (Supplemental
Table S1). The samples on average were evaporatively con-
centrated (i.e., exhibited raised total Na and K concentra-
tions relative to plasma), on average, by ~1.5-fold (see Sup-
plemental Table S1). Isotonic ETT samples, i.e., samples with
minimal evaporative water loss, were identified by selecting
samples with a Na  K value within 10% of the plasma
value. All 15 isotonic samples identified were from nonsmok-
ers without lung disease. Samples that were not within the
normal range of tonicity could theoretically be restored to
isotonicity. However, the effects of evaporative hyperconcen-
tration on mucus properties/organization and their reversibility
with dilution are unknown, so attempts to dilute samples were
not undertaken.
The composition of minimal evaporative loss, i.e., isotonic,
ETT mucus was compared with % solids and Na and K
concentrations of all collected ETT samples. Consistent with
selection criteria, differences were present in Na (Fig. 1A)
and K (Fig. 1B) concentrations between isotonic and whole-
Table 2. Characteristics of pooled endotracheal tube mucus
stock used for rheology
Characteristic Pooled Value
Sample volume, L 2,250
% Solids 4.6
[Na  K]mucus/[Na  K]plasma 1.01
Mucins, g/mL 3,720
Molecular mass, kDa 2.42 	 109
Rg, nm 443.0
Plasma Na and K concentrations ([Na  K]) were taken to be 140 and
4 mM, respectively. Rg, radius of gyration.
set samples (P  0.001). Average sample volumes (Fig. 1C)
and % solids values (Fig. 1D) were not significantly different
between the isotonic samples and the entire set.
Table 1 provides a detailed summary of the patient demo-
graphics and composition of the isotonic samples. Mucus from
these 15 subjects was collected with an average individual ETT
sample volume of 647 L. The mean ETT solids concentration
(4.99%) is in excellent agreement with values reported from
tracheostomies by Matthews et al. (34) (i.e., 5.2%) and is in
reasonable agreement with values for ETT mucus studied by
Schuster et al. (44) (6.9%). The average Na concentration
was 120.00  13.60 mM and K concentration was 30.86 
7.86 mM.
Determination of pooled stock composition. The 2.25 mL
ETT stock pool had a % solids concentration of 4.6%, [Na 
K]/[plasma Na  K] ratio of ~1, and total mucins con-
centration of 3.72 mg/ml (see Table 2). The average molecular
mass of the ETT mucin complexes measured by gel filtration
chromatography and MALLS was 2.42 	 109 Da with a radius
of gyration (Rg) of 443.0 nm. These values are similar to those
for mucin complexes in CF sputum, with an average % solids
of 5.27  1.44%, a molecular mass of 2.4  0.57 	 109 Da,
and Rg of 362  28 nm (n  10). However, when mucins were
isolated by density gradient separation (36) in the presence of
a strong chaotropic agent, i.e., 6 M GuHCl, the molecular mass
of ETT mucus fell to 0.34 	 109 Da and 0.28 	 109 Da for CF
sputum. Rg in these samples also decreased to 294 nm and 234
nm for ETT and CF sputum, respectively. These values were
compared with the molecular mass of mucins isolated by
density gradient from HBE cell culture, where molecular mass
was 0.11 	 109 Da and Rg was 176 nm. Together, these data
indicate that mucus derived from both ETT and CF sputum in
vivo contains mucins assembled into complexes larger than
those formed by cell cultures.
Proteomic analyses using mass spectrometry were employed
to identify the other biomacromolecular constituents of ETT
mucus. The top-20 protein species by intensity from the ETT
mucus pool are listed in Table 3. Both MUC5B and MUC5AC
were detected, in addition to other airway-secreted proteins,
such as lactotransferrin, deleted in malignant brain tumor 1
protein, immunoglobulins, club cell secretory protein, protein
S100, and annexin from airway epithelium (14). Additionally
serum albumin and serotransferrin were present, indicating that
some serum leak into these samples occurred.
Immunohistochemical staining of ETT mucus confirmed the
presence of mucins MUC5AC and MUC5B and identified
Fig. 1. Characteristics of all prospective endotracheal tube (ETT) mucus
samples (All) and of those selected for being nearly isotonic (Iso). A and B:
there were significantly lower (**P  0.001) Na (A) and K (B) concentra-
tions in the isotonic subset (Na: 120.0 mM, K: 30.3 mM) relative to the
average of all samples (Na: 197.9 mM, K: 52.9 mM), indicating that some
dehydration usually occurs during intubation. We also note that K concen-
tration in the isotonic samples was slightly increased above the 25 mM
physiological value (†P  0.05). C: there was no discernable difference in
sample volume between the whole set of samples (581 L) and the isotonic
subset (627 L). D: there was also no difference in % solids between the whole
set and isotonic subset.
Table 3. Top-20 proteins by intensity as detected by mass spectrometry in pooled endotracheal tube mucus
Species Accession No. Alternate ID Molecular Mass, kDa Intensity
Serum albumin ALBU_HUMAN ALB 69 2.02E12
Lactotransferrin TRFL_HUMAN LTF 78 8.64E11
Lysozyme C LYSC_HUMAN LYZ 17 5.83E11
Immunoglobulin heavy constant-1 IGHA1_HUMAN IGHA1 38 5.36E11
Immunoglobulin heavy constant-2 A0A0G2JMB2_HUMAN IGHA2 37 4.79E11
Mucin-5B MUC5B_HUMAN MUC5B 596 4.38E11
Immunoglobulin heavy constant-2 IGHA2_HUMAN IGHA2 37 3.44E11
Immunoglobulin- constant IGKC_HUMAN IGKC 12 2.80E11
CCSP (uteroglobin) UTER_HUMAN SCGB1A1 10 2.34E11
Protein S100-A9 S10A9_HUMAN S100A9 13 2.25E11
Deleted in malignant brain tumors 1 protein DMBT1_HUMAN DMBT1 261 1.64E11
Polymeric immunoglobulin receptor PIGR_HUMAN PIGR 83 1.56E11
Mucin-5AC MUC5A_HUMAN MUC5AC 586 1.39E11
Actin, cytoplasmic 1 ACTB_HUMAN (1) ACTB 42 1.29E11
BPI fold-containing family B member 1 BPIB1_HUMAN BPIFB1 52 1.21E11
Serotransferrin TRFE_HUMAN TF 77 1.15E11
Immunoglobulin -constant 3 IGLC3_HUMAN IGLC3 11 8.79E10
Immunoglobulin heavy constant-1 A0A0A0MS08_HUMAN (1) IGHG1 44 8.67E10
Immunoglobulin -like polypeptide 5 A0A0B4J231_HUMAN (2) IGLL5 23 8.31E10
Annexin A1 ANXA1_HUMAN ANXA1 39 8.30E10
CCSP, club cell secretory protein; BPI, bactericidal/permeability-increasing protein.
associated cell types (Supplemental Fig. S1). A combination of
differential interference contrast imaging and DNA staining
revealed the presence of a number of cell types, including
polymorphonuclear neutrophils, ciliated epithelial cells, and
macrophages (Supplemental Fig. S1, A and B). MUC5B ap-
peared to be the dominant mucin compared with MUC5AC
(Supplemental Fig. S1, C–F), which is in line with the mass
spectrometry results outlined in Table 3 and previous reports
(22). Staining for fibrin (Supplemental Fig. S2B) was positive,
despite limited detection of fibrin or fibrinogen by mass spec-
trometry. A glandular source for at least some of the mucus/
mucin in ETT samples was confirmed by staining for proline-
rich 4 (PRR4) protein (Supplemental Fig. S2C).
Bulk rheology of pooled ETT mucus. We sought to deter-
mine whether pooled ETT mucus exhibited rheologic proper-
ties similar to those reported previously for respiratory mucus
(44). We measured the LVR of the pooled stock over a span of
0.2–10% strain for six separate 40-L volumes of the pooled
sample (Fig. 2, top). From those data, we selected 1% strain to
assess the frequency-dependent viscoelastic moduli. Histori-
cally, a frequency of 1 Hz has been used to compare values of
viscoelastic moduli, because 1 Hz is representative of muco-
ciliary clearance (MCC) mechanics (21, 44). We determined
that G= was always in excess of G over the range of frequen-
cies tested (Fig. 2, bottom). Further, we determined the G-
to-G= ratio at 1 Hz, i.e., tan(), and report a value of 0.29. This
value agrees well with previously reported values and sugges-
tions that mucus obtained from the trachea is a cross-linked
gel (44).
Microrheology of ETT mucus. Thermally driven bead mo-
tion was recorded in two dimensions for 30 s, generating
representative trajectories, as shown in Fig. 3A. Of the four
mucus concentrations prepared by PBS dilution of the pool,
only the beads in the 2% solids samples explored a space
exceeding their diameter over the course of video recording.
The time series of their displacements were converted into
MSDs. The ensemble mean log10(MSD) for each concentration
is shown in Fig. 3B, which illustrates the concentration depen-
dence of bead motion and, hence, concentration dependence of
mucus viscoelasticity. MSD can be related to the lag time of
recorded motion () via the fractional Brownian relation
MSD  D, where 0    1 is the subdiffusive exponent
in the case of constrained thermal motion, as seen in entangled,
elastic, and cross-linked gel systems (19, 28, 29). Only in
purely viscid, dissipative fluids is   1, and then D  4D,
where D is the diffusion coefficient of the bead in its medium.
The exponent  can be calculated as the slope of the curve
log10(MSD) vs. log10() for each sample, as shown in Fig. 3B.
The exponent values are   0.55, 0.45, 0.25, and 0.14 for 2%,
3%, 4%, and 4.6% solid samples, respectively. These data
indicate that all samples exhibited restricted, subdiffusive mo-
tion and that particle motion was increasingly restricted with
increasing concentration.
Comparison of bulk and microrheological measurements.
ETT mucus is believed to be isotropic but not homogeneous
(44). While beads may, therefore, reliably report the viscoelas-
Fig. 2. Viscoelastic moduli of pooled 4.6% endotracheal tube (ETT) mucus.
Top: strain-dependent viscoelastic moduli at 1 radian/s over a range of
0.22–10.0% strain, which was determined to be the linear viscoelastic region.
Bottom: frequency-dependent viscoelastic moduli at 1% strain over a range of
0.016–1.6 Hz (0.1–10 radians). G= is in excess of G over all frequencies,
characteristic of a cross-linked gel.
Fig. 3. Measurement of particle motion
over time for particle-tracking microrheol-
ogy in endotracheal tube (ETT) mucus. A:
particle motion was progressively hin-
dered as mucus concentration increased;
only in 2% mucus were particles able to
probe regions beyond their diameter (scale
bar, 1 m). B: ensemble means of particle
motion represented as mean squared dis-
placement (MSD) vs. lag time (). In log-
log space, MSD curves are linear, and
slopes for each mucus concentration were
less than 1 and decreased with concentra-
tion, indicating subdiffusive motion and
increasingly hindered motion from interac-
tions with the polymer mesh, respectively.
Numbers of beads tracked per concentra-
tion were 650, 474, 1,097, and 189 for 2%,
3%, 4%, and 4.6%, respectively.
ticity of their local environment, they may not sense the
viscoelasticity of the sample at all spatial scales or locales (47).
Conversely, bulk measurements may not capture the local
variations in mesh size and cross-linking density at the mucin-
polymer length scale. To test the features of each measurement
technique, we compared PTMR with bulk measurements. Fig-
ure 4 illustrates this comparison using the complex viscosity

* (Pa·s) at 1 Hz as a combined measure of both the viscosity
and the elasticity of ETT mucus over a range of mucus
concentrations selected for analysis. Mean bulk rheological
measurements of 
* are shown as colored circles (means 
SE; Fig. 4, top). Microrheological measurements are shown as
probability density estimates of 
* for the ensemble of all
beads in a given sample. These estimates were generated using
the Matlab (2018, MathWorks) function ksdensity.
Mean values of mucus complex viscosity as obtained from
both methodologies are in good general agreement. The much
wider variability of 
* observed via PTMR indicates that the
beads are able to probe the random microstructural variations
of the samples. That the two methodologies generally agree
indicates that the size of the PTMR bead, i.e., slightly larger
than the mesh size, accurately sampled the heterogeneous
microstructure of the mucus gel that imparts the macroscopic
viscoelasticity of the gel.
Biochemical comparison of ETT mucus, HBE mucus, and
normal induced sputum. HBE mucus is an in vitro model for
studying the biophysics and biochemistry of airway mucus (18,
19). However, questions have been raised regarding its simi-
larity to native airway mucus and, therefore, its suitability as a
model system. We prepared a stock of HBE mucus for com-
parison with a second pool of ETT mucus from the same 15
subjects and measured the protein composition of ETT and
HBE mucus using MALLS. These measurements were also
compared with the reported average values from 15 induced
sputum (IS) samples collected from healthy subjects as part of
a previous study (38). In general, measurements of the second
ETT pool agreed well with the first pool results presented in
Table 2. Mucin concentration was 4.44 mg/ml in the ETT
pool and and 6.12 mg/ml in the HBE mucus pool (Fig. 5A),
are similar to those reported by Matsui and colleagues in
HBE mucus (33) and Schuster et al. in ETT mucus (44).
Average mucin concentration was 1.64 mg/ml in the IS
samples (Fig. 5A).
Total nonmucin protein concentration was 11.8 mg/ml in
ETT mucus and 7.16 mg/ml in HBE mucus as calculated from
refractometry using a desalting column. A desalting column
was not used on IS samples as part of their analysis during the
previous study (38). Therefore, the value of total nonmucin
protein in IS samples was estimated as average solids content
[1.2% solids, as previously reported (38)] minus mucin content
(0.164%) and salt content, which was estimated from induc-
tively coupled plasma atomic emission spectroscopy (ICP-
OES) measurements of Na and K concentrations. Briefly,






65.2 mM  15.6 mM
120 mM  25 mM
 0.9%  0.5%
Accordingly, nonmucin protein concentration was deter-
mined to be 0.53%, or 5.3 mg/ml, for IS. The total nonmucin
protein concentrations for each sample type are illustrated in
light gray in Fig. 5A. Figure 5B shows that ETT mucus had a
Fig. 4. Comparison of endotracheal tube (ETT) mucus bulk (macro) rheology
to particle-tracking microrheology (PTMR). Bulk rheological measurements
(dots, means  SE) of complex viscosity (
*) agree well with the central
tendencies of the PTMR ensemble distributions (filled regions) of 
* in all
mucus concentrations. PTMR 
* distributions are represented as kernel-
smoothed estimates of the probability density. The ordinate value chosen for
bulk measurements was arbitrary.
Fig. 5. Mucin and protein composition in endotracheal tube (ETT), induced
sputum (IS), and human bronchial endothelial (HBE) mucus via multiangle
laser light scattering (MALLS). A: total solids composition of ETT, IS, and
HBE mucus as % salts (0.9% ETT vs. 0.9% HBE vs. 0.5% IS), mucins (0.44%
ETT vs. 0.61% HBE vs. 0.164% IS), and other proteins (1.18% ETT vs. 0.72%
HBE vs. 0.53% IS). B: mucin-to-other protein ratio in ETT (0.27), IS (0.23),
and HBE (0.46). C: molecular mass of mucins in ETT (2.28 	 109 Da), IS
(5.31 	 108 Da), and HBE (4.10 	 108 Da). D: radius of gyration (Rg) of
mucins in ETT (440.9 nm), IS (351.7 nm), and HBE (171.9 nm) mucus. Error
bars show means  SD.
mucin-to-total protein ratio of 0.27 that is roughly twofold
lower than the 0.46 of HBE mucus. In contrast, IS had a
mucin-to-total protein ratio of 0.23, or roughly equal to that of
ETT.
The molecular mass and size of ETT samples analyzed by
MALLS without prior density gradient centrifugation were
also compared with values for IS and HBE. The molecular
mass of the mucus peak components of ETT samples (2.28 	
109  0.2 	 109 Da, means  SD of both pools) was roughly
four to five times greater than that of IS (5.3  4.0 	 108 Da,
n  15 historical samples) or HBE (4.1  1.6 	 108 Da, n 
8 historical samples) (Fig. 5C). This difference was associa-
ted with an increase in radius of gyration for ETT mucus
(440.9  2.9 nm) vs. IS (351.7  60.4 nm) or HBE (171.9 
25.2 nm) mucus (Fig. 5D).
Taken together, these findings indicate that the concentra-
tions of mucin in ETT and HBE mucus are roughly similar.
However, the total protein content is higher in ETT mucus,
and the mucin percentage of total protein lower, reflecting
addition of serum and, likely, general airway epithelial
proteins in ETT samples. Sputum induction is known to
dilute samples (16) and is associated with salivary contam-
ination, which may explain the relatively low mucin con-
centrations in the IS samples. That the relative proportion of
mucins among total proteins is preserved by correcting for
salivary dilution based on salt concentration indicates that
salivary contamination likely occurred.
Glycosylation of ETT, HBE, and CF sputum samples. Gly-
cosylation of the mucin VNTR regions can be a key determi-
nant of mucin properties. We compared the O-linked glycan
profiles of ETT mucus (n  3) with the profiles of HBE (n 
3) and IS (n  3). Among the most abundant O-linked glycans,
13 nonsulfated and 8 sulfated structures were shared across the
three sample types. These structures, as well as less abundant
glycans that were detectable but not quantifiable, demonstrated
the expected heterogeneity arising from normal human genetic
variation in the fucosyltransferase encoded at the secretor (sec)
locus. This heterogeneity was detected as increased addition of
fucose (Fuc) to glycans harvested from sec/ individuals and
increased addition of sialic acid (NeuAc) in sec/ individuals.
Glycans harvested from sec/ individuals exhibit intermedi-
ate relative abundances of NeuAc and Fuc addition (35).
Samples of ETT and IS mucus were obtained from all three
secretor genotypes, and HBE cells were prepared in three
biological replicates from sec/ subjects. The relative abun-
dance of nonsulfated glycans was compared across samples by
hierarchical clustering (49) and demonstrated that sec/ sta-
tus segregated the glycan profiles of ETT, sputum, and HBE
away from the other two genotypes (Fig. 6, left). Thus, non-
sulfated glycan profiles distinguished the secretor status of the
donor more than the source of the material (ETT, IS, HBE).
However, for sulfated glycans, ETT and HBE profiles segre-
gated away from healthy IS samples regardless of secretor
status, and hierarchical clustering of sulfated glycans failed to
detect differences between HBE cells and ETT mucus (Fig. 6,
right); sulfated glycan profiles indicated greater similarity
between ETT mucus and HBE cells than between HBE/ETT
mucus and IS. Furthermore, this difference was observed
independent of the secretor status of the donor (24, 30, 43). The
major factor driving the clustering of IS away from HBE/ETT
was the reduced structural complexity of the sulfated glycans
in IS compared with HBE/ETT. The relative abundance of a
single glycan (sulfated glycan #5) dominates the IS profile
compared with the greater diversity of sulfated structures
detected in HBE and ETT (Fig. 6, right). In HBE and ETT,
sulfated glycan #5 is also highly abundant but shares the status
of highest relative abundance with sulfated glycan #3, the
sialylated form of sulfated glycan #5. Reduced relative abun-
dance of sialylated glycans in IS was also detected in the
nonsulfated glycans (Fig. 6, left). The three most abundant
sialylated, nonsulfated glycans (nonsulfated structures #5, 6,
and 7, Fig. 6, left) accounted for 34  13, 48  8, and 77  2%
(means  SE) of the total nonsulfated glycan profile for IS,
ETT, and HBE, respectively. Thus, in comparison to induced
sputum, ETT and HBE mucus is characterized by a higher
relative abundance of sialylated and sulfosialylated glycans.
Biophysical comparison of ETT mucus with HBE mucus.
Because increased mucus concentration (i.e., isotonic dehydra-
tion) is a primary pathophysiologic variable in MOLDs, such
as CF (2, 7, 18, 19, 33), we sought to determine whether the
concentration dependence of mucus viscoelasticity was similar
in ETT and HBE mucus. Hill and colleagues (19) previously
performed a concentration-dependent microrheological analy-
sis of HBE mucus over a range of concentrations similar to
those utilized in the present study. Figure 7A demonstrates
close agreement for 
* in ETT (blue curves) and HBE (orange
curves) mucus across this range of concentrations. Two-way
ANOVA revealed that concentration had a significant effect on
changing 
*, while sample type did not. Additionally, a nearly
identical scaling behavior as seen in ETT and HBE mucus was
found in sputum samples from individual patients with CF
(Supplemental Fig. S3).
Frequency responses as measured by PTMR in ETT vs.
HBE mucus illustrated that while agreement was not perfect
between sample types at 2% (Fig. 7B), 3% (Fig. 7C), and 4%
(Fig. 7D), it was better than within concentrations for each
sample type, as determined at 1 Hz by two-way ANOVA (P 
0.05 for % solids vs. P  not significant for sample type). Put
simply, concentration had more influence than sample origin
on viscoelastic properties. This conclusion was also borne out
at 0.1 and 10 Hz (see Supplemental Fig. S4). These findings
indicate that both sample types may be useful for studying the
viscoelastic mechanics of healthy airway mucus across a range
of concentrations. Notably, the loss modulus G was greater
than G= in all samples except 4% solids ETT, in line with data
Hill and colleagues had previously reported in HBE regarding
a sol-gel transition occurring near that concentration (19).
DISCUSSION
To study the rheologic properties of the mucus that normally
lines airway surfaces, an abundant, minimally invasive, and
representative source of airway mucus is needed. Endotracheal
tube mucus has been analyzed as a source of airway mucus in
a few studies (10, 44) and compared with other sample types
and model systems. In this work, we expand on previous
reports by performing a detailed biochemical and biophysical
analysis of ETT mucus obtained from healthy subjects under
conditions designed to mimic the native airway environment.
Our studies established that, from a total of 77 samples, we
could identify 15 separate isotonic patient ETTs that, when
combined, produced a stock with a volume greater than the
volume generated from 1 mo of harvesting HBE mucus from
100 HBE cultures (on 1 cm2 inserts). Human bronchial
epithelial cells have been a gold standard for mucus produc-
tion, because HBE cultures recapitulate many of the compo-
nents of the MCC mechanism in airways, including secretory
cell mucus production and coordinated, mucomotive ciliary
beat. For this reason, despite the labor-intensive requirement to
produce small mucus volumes, HBE cultures have been widely
used to study MOLDs (17, 19, 20, 33). However, questions
remain as to whether the absence of gland mucus and the
normal plasma proteins that passively permeate into mucus
limit HBE mucus as being representative of in vivo airway
mucus. Induced sputum from healthy subjects is minimally
invasive, but inhalation of hypertonic saline (HS) for induction
is time/medical personnel-consuming. Notably, HS induction
may dilute mucus by ~25% (15), and salivary contamination
generates a second form of dilution.
In addition to the relative ease of obtaining ETT mucus, ETT
mucus is attractive as a source of mucus because it is an “in
vivo”-produced airway mucus. ETT mucus can also be ob-
tained in relatively large (0.6 mL/ETT; Fig. 1A) volumes
multiple times per week as a by-product of surgeries performed
on subjects without respiratory disease. These sample volumes
would be sufficient to use with methods that require larger
aliquots [e.g., 3 L for flame photometry (25)] to accurately
assess ion concentration for those without access to ICP-OES
equipment. Typical ETT samples, on average, were composed
of ~5.6  2.8% solids (Fig. 1, bottom right) and exhibited Na
and K concentrations that were ~1.5-fold greater than ASL
and plasma values (Fig. 1, bottom left). This hypertonicity is
likely explained by evaporative water loss during mechanical
ventilation. However, 15 of 77 samples exhibited sums of
cations, i.e., Na and K, that were within 10% of plasma Na
and K and, hence, were isotonic with minimal evaporative
water loss (Table 1). We pooled these samples for studies of
ETT mucus to avoid potential artifacts associated with samples
that experienced evaporation and would require water dilution
to restore isotonicity (Table 2). Furthermore, salt concentration
has been shown to have a significant effect on the biophysical
behavior of mucin gels (47), underscoring the utility of a
sample type with physiological electrolyte composition.
Fig. 6. Hierarchical clustering of O-linked glycan profiles of endotracheal tube (ETT) mucin, sputum (S), and human bronchial epithelial (HBE) cells. Left:
nonsulfated O-linked glycans were harvested and analyzed by nanospray ionization multidimensional mass spectrometry (NSI-MSn) in positive-ion mode. The
13 highest-abundance O-linked glycans detected in ETT mucus (ETT), sputum (S) from healthy subjects, and human bronchial epithelial cells cultured at an
air-liquid interface (HBE) were quantified as the percentage of the signal intensity that each individual glycan contributed to the total signal intensity for all 13
glycans (percentage of total profile). Based on the total glycan profile, donors of the indicated samples were characterized as sec/, sec/, or sec/ for the
fucosyltransferase activity encoded at the human secretor (sec) locus. Hierarchical clustering was performed to assess the closest similarities across the samples.
Sec/ samples segregated together, regardless of their source (ETT, S, or HBE), indicating that secretor status outweighs sample source as a determinant of
nonsulfated glycosylation. Right: sulfated O-linked glycans were harvested and analyzed by NSI-MSn in negative-ion mode. The relative abundance of the 7 most
abundant sulfated O-linked glycans detected in all three sample types were quantified and compared with each other as percentage of total profile. Hierarchical
clustering of sulfated glycan abundance demonstrates greater similarity between ETT mucus and HBE cells than between ETT mucus and sputum. The
similarities in sulfated glycan profiles are independent of secretor status. Graphical representations of monosaccharide residues are in accordance with the broadly
adopted Symbolic Nomenclature for Glycans guidelines (SNFG).
Cone-and-plate rheometry revealed that mucus from the
pooled ETT stock exhibited viscoelastic properties that were
virtually identical to the average of previously reported indi-
vidually tested ETT samples (41, 44). Figure 2 illustrates that
the pooled sample behaved as a viscoelastic, cross-linked gel,
and computation of tan() at 1 Hz (0.29) revealed viscous and
elastic properties close to tan()  0.3 reported by Schuster et
al. (44) and tan()  0.33 reported by Rubin et al. (41) for ETT
mucus. This data set suggests that pooling ETT mucus into
large volumes did not alter the bulk rheological behavior of
native mucus and offers the advantage of providing for larger
working volumes of airway mucus for well-controlled mac-
rorheological analyses.
PTMR is useful in the analysis of entangled and cross-linked
gels, because it can reveal the viscous and elastic properties of
the gel at the scale of its polymer network (48). Hindered (i.e.,
non-Brownian, subdiffusive) bead motion is related to the
elasticity of the gel, while diffusion is reflective of the dissi-
pative properties of the interstitial liquid within the mesh.
These two elements can be visualized in Fig. 3A, where, at 2%
solids concentrations, the polystyrene beads were able to move
beyond their own diameter over the time course of the exper-
iment. At 3% solids concentration, bead motion was “caged” to
an area within its own diameter. At higher solids concentra-
tions, bead motion was severely constrained. This caging is
also illustrated in Fig. 3B, where the base-10 logarithm of the
mean squared displacements of bead motion are plotted against
the logarithm of lag time, . In purely viscid liquids, the slope
of the log-transformed curve is   1. As elastic interactions
between beads and mucus increase, the slope decreases as bead
motion became more restricted. The concentration-dependent
decrease in MSD in Fig. 3B is reflective of the concentration-
dependent increase in mucus gel stiffness that contributes to
failure of MCC in MOLDs.
PTMR is also an important methodology for the study of the
biophysical properties of mucus, because it is able to capture
the innate heterogeneity of the fluid on the length scale of its
molecular constituents. By evaluating the rheology explored by
an ensemble of beads in a sample type, the “rheological
topology” of a sample can be determined, sometimes revealing
emergent behaviors compared with bulk measurements. Figure
4 illustrates this feature, where the mean viscoelastic character
of the mucus was similar for bulk and PTMR measurements.
However, the PTMR measurements were more heterogeneous.
In particular, the probability density estimate of the 2% solids
ensemble reveals rheologies across nearly 3 logs of 
* and a
clear bimodality. However, the central tendency of the ensem-
ble PTMR data was in agreement with bulk mean values,
suggesting that bulk rheological measurements provide a
coarse-grain survey of the biophysical properties of a sample.
The bimodality of the 2% sample is notable for the similarity
of its higher-viscosity mode to the distribution of the 3%
sample. As these samples were obtained via serial dilution, it
may be that the two modes represent a snapshot of a transition
between phases. Georgiades and colleagues (12) reported that
the transition between entanglement and overlap in porcine
gastric and duodenal mucus was between 2% and 3% solids,
respectively. It may be that our samples were not fully mixed
into the PBS diluent to form a uniform phase.
Relevant biochemical characterizations of ETT mucus are
the absolute mucin concentration and the ratio of mucin to
“other” biologic molecule composition and how those values
compare with HBE mucus and IS from normal subjects. Figure
5A illustrates the total solids content of ETT, IS, and HBE
mucus. Mucin complexes comprised slightly more than 0.5%
of both ETT and HBE samples, with ETT mucin complexes
measured at 4.44 mg/ml and HBE mucins at 6.12 mg/ml, while
IS samples had lower mucin concentrations of 1.64 mg/ml.
Differences were also observed in the quantity of nonmucin
proteins in the samples. ETT mucus (11.8 mg/ml) had abso-
lutely more nonmucin protein material than IS (5.35 mg/ml)
and HBE mucus (7.16 mg/ml).
Figure 5B illustrates the differences in mucin-to-other pro-
tein ratios between ETT, IS, and HBE samples. The proteomics
data identified the source of increased nonmucin proteins in
ETT versus HBE as serum leak proteins (albumin) and airway
epithelial proteins that may be glandular in origin. Thus, ETTs
may sample a broader variety of proteins that normally are part
of mucus in vivo than HBE cells. The relatively similar
proportions of mucin and nonmucin proteins may be explained,
at least in part, by the dilution of both mucins and nonmucin
protein by HS induction. The possible contribution of salivary
contamination to IS mucin/nonmucin protein concentrations is
unknown. The data also indicate that rough comparisons of
mucin concentrations between in vivo samples and/or HBE
samples based on % solids may be inaccurate.
Fig. 7. Comparison of particle-tracking microrheology measurements of vis-
coelasticity in endotracheal tube (ETT, blue) and human bronchial endothelial
(HBE, orange) mucus. A: complex viscosity (
*) in ETT and HBE mucus.
Slopes of lines of best fit for HBE and ETT excluding 2% were m  5.2 and
m  4.9, respectively, similar to values reported by Georgiades and colleagues
(12) for porcine duodenal mucus. Best-fit slope for all ETT concentrations was
3.7, similar to Georgiades et al. report of 3.9 in porcine gastric mucus. B:
viscous modulus (G) exceeded the loss modulus (G=) for both 2% HBE and
ETT mucus, characteristic of a sol. Both measures agreed well between sample
types. C: general agreement was also observed for G= and G between sample
types at 3% solids with G again exceeding G= in ETT and HBE samples. D:
values G= and G were near to each other in both 4% solids ETT and HBE
mucus, indicating proximity to the sol-gel transition point, with similarities
between sample types as well. However, G= exceeded G in ETT indicating
that ETT mucus had undergone transition to a gel, whereas Hill et al. (19)
previously reported that HBE mucus does not undergo this transition until %
solids is just above 4%. [All HBE data reproduced from Hill et al. (19), with
permission under the Creative Commons Attribution 4.0 Unported License.]
We also performed MALLS with pooled ETT mucus for
comparison with HBE and IS samples with nominally identical
% solids content. Figure 5, C and D, illustrates that the starkest
difference between ETT mucus, IS, and HBE mucus was in the
size of their mucin complexes. ETT mucins formed enormous
complexes with molecular mass of 2.28 GDa (Fig. 5C) and Rg
of 440.9 nm (Fig. 5D), respectively. In contrast, HBE mucins
formed smaller complexes with molecular mass of 410.0 MDa
and Rg of 171.9 nm. IS was associated with smaller complexes
but similar Rg. When mucins from all sample types were
exposed to isopycnic centrifugation, molecular mass of ETT
mucus fell and was similar to values reported for IS and HBE
mucus, with molecular mass of 338 MDa. The large complexes
found in ETT mucus before chaotropic, isopycnic isolation
may be formed due to the presence of mucin interactions with
globular proteins, aggregation of mucins with inhaled particles,
or large submucosal gland extrusions (11) not found in HBE
cultures. Furthermore, because the IS samples appeared to
suffer from salivary contamination, as evidenced by dilute ion
concentrations relative to ASL values, the IS molecular mass
and Rg values may reflect a component of salivary mucin
complexes that have been reported to have molecular mass of
roughly 10–40 MDa and proportionate Rg values (39). To-
gether, these data indicate that studies of large-molecular-
weight macromolecular forms of mucins may be best per-
formed in ETT samples.
The hydrophilic nature and anionic charge of the glycans
attached to mucins contribute significantly to the physicochem-
ical properties of mucus. Our glycomics analysis demonstrated
that ETT and HBE mucus were more similar to each other than
to IS from healthy individuals (Fig. 6). The O-linked glycans of
ETT and HBE, in comparison to IS, exhibited greater relative
abundance of nonsulfated sialylated glycans and of sulfated
sialylated glycans. These glycomic signatures may reflect in-
teresting, but currently uncharacterized, differential expression
of specific sulfo- and sialyltransferases in the secretory epithe-
lia from which the mucus is derived. Alternatively, sputum
glycans may be susceptible to desialylation by host salivary or
microbial sialidases that do not have access to O-linked gly-
cans harvested through ETT or are not present in the aseptic
environment of HBE cultures. Our observation that the major
O-linked glycans of ETT mucus were more similar to HBE
mucin glycans than IS glycans suggests that IS may not
appropriately reflect the characteristics of airway mucus and, to
the extent that glycosylation influences mucus function, may
not be a representative sample type for study of the physico-
chemical properties of airway mucus.
Using PTMR, we were able to compare the rheology of ETT
mucus with HBE mucus. Figure 7A illustrates that the com-
posite viscoelasticity (as 
*) was similar for each sample type
and that each displayed a similar dependence on concentration.
Viscosity has a power law dependence on concentration that
can be calculated from the slope (m) of the curve log10(
*) vs.
log10(c). Our reported values for HBE (m  5.2) and ETT
mucus above 2% solids (m  4.9) agree well with values
reported by Georgiades et al. in porcine duodenal mucus under
entanglement regimens (12). If concerns regarding the phase
(i.e., overlap vs. entanglement) implications of the bimodality
in 2% ETT mucus are disregarded, adding its reported viscos-
ity to the fit yields m  3.74, which agrees with the values
reported by Georgiades et al. for porcine gastric mucus, where
m  3.92. Additionally, the behavior of these pooled samples
agreed well with data from individual CF sputum samples
(Supplemental Fig. S3).
We also used PTMR to compare the frequency responses of
ETT and HBE mucus. Values for G= and G were in good
agreement for both sample types at 2% solids concentration,
particularly at higher frequencies (Fig. 7B). Generally good
agreement was also found between ETT and HBE mucus at 3%
solids (Fig. 7C). In all 2% and 3% measurements, G exceeded
G=, which is characteristic of a viscoelastic sol (19). At 4%
solids, G= and G were similar in ETT mucus, as has been
reported previously by Hill and colleagues (19). In contrast to
previous and current (Fig. 7A) HBE data, G= exceeded G in
ETT mucus of 4% solids concentration. This behavior is
characteristic of a viscoelastic gel, implying that between 3%
and 4% solids, ETT mucus undergoes a sol-gel transition,
whereas HBE mucus undergoes a similar transition at just
above 4% solids (19). Despite this difference between the two
sample types, ETT samples provide a source of native airway
mucus that has both sol and gel phases and viscoelastic
behavior similar to other mucus types.
In conclusion, this study describes extended biochemical
and biophysical analyses of native human airway mucus ob-
tained from endotracheal tubes (ETTs). We selected and com-
bined mucus obtained only from ETTs with salt concentrations
similar to those found in the airway surface liquid, i.e., with
minimal evaporative water loss. A large volume of pooled ETT
mucus samples behaved rheologically similarly to previous
reports of individual ETT samples. The pooled samples were
tunable with respect to mucus concentration while maintaining
physiological (isotonic) Na and K concentrations. Our bio-
physical measurements agreed well with previous studies in
other mucus types, including mucus obtained from HBE cell
cultures in this and previous work, where sample volumes can
be prohibitively small. ETT mucus may have a broader repre-
sentation of endogenous nonmucin organic molecules that may
contribute to mucin organization in vivo. In summary, ETT
mucus is a viable source of large volumes of native, tunable
airway mucus for the study of muco-obstructive airway dis-
eases.
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